Colorectal Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colorectal Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 3 (2006), Issue 12 (December)

1. MDM2 SNP309 accelerates colorectal tumour formation in women.
   J Med Genet, 43(12): 950-2. [Abstract] [Full-text]
2. Wnt signalling and the actin cytoskeleton.
   Oncogene, 25(57): 7538-44. [Abstract] [Full-text]
3. Colorectal cancer and genetic alterations in the Wnt pathway.
   Oncogene, 25(57): 7531-7. [Abstract] [Full-text]
4. Expression and prognostic significance of angiopoietin in colorectal carcinoma.
   J Surg Oncol, 94(7): 631-8. [Abstract] [Full-text]
5. Different modulation of TRAIL-induced apoptosis by inhibition of pro-survival pathways in TRAIL-sensitive and TRAIL-resistant colon cancer cells.
   FEBS Lett, 580(28): 6565-9. [Abstract] [Full-text]
6. A novel system to study adenovirus tropism to normal and malignant colon tissues.
   Virology, 357(1): 91-101. [Abstract] [Full-text]
7. Prognostic value of cell cycle and apoptosis regulatory proteins in mismatch repair-proficient colorectal cancer: a tissue microarray-based approach.
   Am J Clin Pathol, 127(1): 114-23. [Abstract] [Full-text]
8. Allelotyping analyses of synchronous primary and metastasis CIN colon cancers identified different subtypes.
   Int J Cancer, 120(3): 524-32. [Abstract] [Full-text]
9. The prognostic significance of thymidylate synthase and dihydropyrimidine dehydrogenase in colorectal cancer of 303 patients adjuvantly treated with 5-fluorouracil.
   Int J Cancer, 120(3): 694-701. [Abstract] [Full-text]
10. Familial adenomatous polyposis patients have high levels of arachidonic acid and docosahexaenoic acid and low levels of linoleic acid and alpha-linolenic acid in serum phospholipids.
    Int J Cancer, 120(3): 632-7. [Abstract] [Full-text]
11. Risk and risk reduction involving arginine intake and meat consumption in colorectal tumorigenesis and survival.
    Int J Cancer, 120(3): 459-68. [Abstract] [Full-text]
12. MDM2 SNP309 T>G alone or in combination with the TP53 R72P polymorphism does not appear to influence disease expression and age of diagnosis of colorectal cancer in HNPCC patients.
    Int J Cancer, 120(3): 563-5. [Abstract] [Full-text]
13. Successful cancer vaccine therapy for carcinoembryonic antigen (CEA)-expressing colon cancer using genetically modified dendritic cells that express CEA and T helper-type 1 cytokines in CEA transgenic mice.
    Int J Cancer, 120(3): 585-93. [Abstract] [Full-text]
14. PPARgamma inhibitors reduce tubulin protein levels by a PPARgamma, PPARdelta and proteasome-independent mechanism, resulting in cell cycle arrest, apoptosis and reduced metastasis of colorectal carcinoma cells.
    Int J Cancer, 120(3): 702-13. [Abstract] [Full-text]
15. Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer.
    Int J Cancer, 120(3): 656-63. [Abstract] [Full-text]
16. Alcohol intake and colorectal cancer risk: a dose-response meta-analysis of published cohort studies.
    Int J Cancer, 120(3): 664-71. [Abstract] [Full-text]
17. Progression of tumors arising from large ACF is associated with the MUC5AC expression during rat colon MNNG carcinogenis.
    Int J Cancer, 120(3): 477-83. [Abstract] [Full-text]
18. Diagnostic accuracy of colorectal cancer staging with whole-body PET/CT colonography.
    JAMA, 296(21): 2590-600. [Abstract] [Full-text]
19. Conformal radiotherapy of the dominant liver metastasis: a viable strategy for treatment of unresectable chemotherapy refractory colorectal cancer liver metastases.
    Am J Clin Oncol, 29(6): 562-7. [Abstract] [Full-text]
20. Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer.
    J Natl Cancer Inst, 98(23): 1731-8. [Abstract] [Full-text]
21. Perioperative strategy in colonic surgery; LAparoscopy and/or FAst track multimodal management versus standard care (LAFA trial).
    BMC Surg, 6: 16. [Abstract] [Full-text]
22. Evaluation of safety of increased time interval between chemoradiation and resection for rectal cancer.
    Am J Surg, 192(6): 873-7. [Abstract] [Full-text]
23. Ethylenediaminetetraacetic acid affects subcellular expression of clusterin protein in human colon adenocarcinoma COLO 205 cell line.
    Anticancer Drugs, 18(1): 55-63. [Abstract] [Full-text]
24. Evaluation of 5-fluorouracil applicability by the collagen gel droplet embedded drug sensitivity test with area under the curve analysis.
    Anticancer Drugs, 18(1): 17-21. [Abstract] [Full-text]
25. Panitumumab the first fully human monoclonal antibody: from the bench to the clinic.
    Anticancer Drugs, 18(1): 7-15. [Abstract] [Full-text]
26. Update on colorectal cancer imaging.
    Radiol Clin North Am, 45(1): 85-118. [Abstract] [Full-text]
27. Transanal endoscopic microsurgery for carcinoma of the rectum.
    Surg Endosc, 21(1): 97-102. [Abstract] [Full-text]
28. Restorative proctectomy with colon pouch-anal anastomosis by laparoscopic transanal pull-through: an available option for low rectal cancer?
    Surg Endosc, 21(1): 91-6. [Abstract] [Full-text]
29. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy.
    N Engl J Med, 355(24): 2533-41. [Abstract] [Full-text]
30. Reduced expression of CYLD in human colon and hepatocellular carcinomas.
    Carcinogenesis, 28(1): 21-7. [Abstract] [Full-text]
31. Frequent occurrence of uniparental disomy in colorectal cancer.
    Carcinogenesis, 28(1): 38-48. [Abstract] [Full-text]
32. Evaluation of laser microdissection as a tool in cancer glycomic studies.
    Biochem Biophys Res Commun, 352(3): 579-86. [Abstract] [Full-text]
33. Characterization of a novel oncogenic K-ras mutation in colon cancer.
    Biochem Biophys Res Commun, 352(3): 728-32. [Abstract] [Full-text]
34. Expression and genomic profiling of colorectal cancer.
    Biochim Biophys Acta, 1775(1): 103-37. [Abstract] [Full-text]
35. Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer.
    JAMA, 296(23): 2815-22. [Abstract] [Full-text]
36. Clinical value of manual fusion of PET and CT images in patients with suspected recurrent colorectal cancer.
    AJR Am J Roentgenol, 188(1): 257-67. [Abstract] [Full-text]
37. Development of a cathartic-free colorectal cancer screening test using virtual colonoscopy: a feasibility study.
    AJR Am J Roentgenol, 188(1): W29-36. [Abstract] [Full-text]
38. Hormone replacement therapy and survival after colorectal cancer diagnosis.
    J Clin Oncol, 24(36): 5680-6. [Abstract] [Full-text]
39. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients.
    J Clin Oncol, 24(36): 5672-9. [Abstract] [Full-text]
40. Detection of spatial clusters: application to cancer survival as a continuous outcome.
    Epidemiology, 18(1): 73-87. [Abstract] [Full-text]
41. Effect of directed training on reader performance for CT colonography: multicenter study.
    Radiology, 242(1): 152-61. [Abstract] [Full-text]
42. Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: final results of a randomised, controlled, multicenter phase II study.
    Invest New Drugs, 25(2): 173-80. [Abstract] [Full-text]
43. Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study.
    Surgery, 141(1): 67-75. [Abstract] [Full-text]
44. Meta-analysis of clinical outcome after first and second liver resection for colorectal metastases.
    Surgery, 141(1): 9-18. [Abstract] [Full-text]
45. A putative transcriptional elongation factor hIws1 is essential for mammalian cell proliferation.
    Biochem Biophys Res Commun, 353(1): 47-53. [Abstract] [Full-text]
46. A comparative study of volumetric analysis, histopathologic downstaging, and tumor regression grade in evaluating tumor response in locally advanced rectal cancer following preoperative chemoradiation.
    Int J Radiat Oncol Biol Phys, 67(1): 204-10. [Abstract] [Full-text]
47. Matrix metalloproteinase-9 expression correlated with tumor response in patients with locally advanced rectal cancer undergoing preoperative chemoradiotherapy.
    Int J Radiat Oncol Biol Phys, 67(1): 196-203. [Abstract] [Full-text]
48. Apoptotic effect of EGCG in HT-29 colon cancer cells via AMPK signal pathway.
    Cancer Lett, 247(1): 115-21. [Abstract] [Full-text]
49. Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer.
    J Clin Oncol, 25(1): 110-7. [Abstract] [Full-text]
50. Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patients.
    J Clin Oncol, 25(1): 102-9. [Abstract] [Full-text]
51. Voltage-gated K+ channels support proliferation of colonic carcinoma cells.
    FASEB J, 21(1): 35-44. [Abstract] [Full-text]
52. Nuclear export is essential for the tumor-promoting activity of survivin.
    FASEB J, 21(1): 207-16. [Abstract] [Full-text]
53. Increased risk of breast cancer associated with CHEK2*1100delC.
    J Clin Oncol, 25(1): 57-63. [Abstract] [Full-text]
54. Colon carcinoma cells induce CXCL11-dependent migration of CXCR3-expressing cytotoxic T lymphocytes in organotypic culture.
    Cancer Immunol Immunother, 56(3): 359-70. [Abstract] [Full-text]

© 2004-2010 Colorectal Cancer Research Today. All Rights Reserved.